UK Campaign to Stop Genetically Modified Human Embryos
By Marcy Darnovsky,
Genetic Crossroads
| 02. 28. 2007
The UK-based Human Genetics Alert (HGA) has launched a campaign to prevent Britain from becoming the first country in the world to sanction the production of genetically modified human embryos. As reported in the January issue of Genetic Crossroads, a bill set to be introduced would allow British scientists to begin developing technologies that could be used in efforts toward inheritable genetic modification.
Speaking at an HGA press conference, Dr. Richard Nicholson, editor of the Bulletin of Medical Ethics, said, "Every country that has legislated on this subject has banned it. Thus the British Government's decision breaks ranks with the international community, and may lead to the perception that Britain is a haven for irresponsible and profit-driven scientists."
The proposed law maintains the UK's existing ban on creating genetically modified children. But although the white paper supporting the proposed legislation says that genetically altering eggs, sperm and embryos "should not be permitted for reproductive purposes," it adds that this is only "for the foreseeable future, and until such time as safety and efficacy are assured."
HGA Director Dr...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...